Position in NVS
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$403,710
+$10,226 QoQ
Shares Held
2,576
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#989
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Grey Ledge Advisors, LLC holds $20,654,452 across 8 Drug Manufacturers - General names. NVS ranks #8 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
27,060 | $6,872,428 | |
| 2 | AMGN |
Amgen Inc
|
13,311 | $4,820,179 | |
| 3 | MRK |
Merck & Co., Inc.
|
32,342 | $4,155,947 | |
| 4 | LLY |
ELI LILLY & Co
|
1,255 | $1,505,284 | |
| 5 | ABBV |
AbbVie Inc.
|
4,550 | $1,144,962 | |
| 6 | NVO |
Novo Nordisk A S
|
21,878 | $1,048,831 | |
| 7 | PFE |
Pfizer Inc
|
29,199 | $703,111 | |
| 8 | NVS |
Novartis AG
This page
|
2,576 | $403,710 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $403,710 | 2,576 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $393,484 | 2,576 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $354,739 | 2,573 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $329,961 | 2,573 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $311,358 | 2,573 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $286,280 | 2,568 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $249,794 | 2,567 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $295,371 | 2,568 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $273,389 | 2,568 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $247,918 | 2,563 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $258,786 | 2,563 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $261,067 | 2,563 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $441,279 | 4,373 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $402,316 | 4,373 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $396,264 | 4,368 | Shares | Sole | 2023-02-16 | |
| 2022-09-30 | $332,011 | 4,368 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $369,227 | 4,368 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $383,292 | 4,368 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $381,719 | 4,364 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $344,293 | 4,210 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $416,419 | 4,564 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $390,130 | 4,564 | Shares | Sole | 2021-08-11 | |
| 2020-12-31 | $397,550 | 4,210 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $366,101 | 4,210 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $367,701 | 4,210 | Shares | Sole | 2020-08-18 | |
| 2020-03-31 | $347,114 | 4,210 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||